These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22972598)

  • 41. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification.
    Kalantari P; Narayan V; Henderson AJ; Prabhu KS
    FASEB J; 2009 Aug; 23(8):2366-73. PubMed ID: 19299483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system].
    Merino JJ; Montes ML; Blanco A; Bustos MJ; Oreja-Guevara C; Bayon C; Cuadrado A; Lubrini G; Cambron I; Munoz A; Cebolla S; Gutierrez-Fernandez M; Bernardino JI; Arribas JR; Fiala M
    Rev Neurol; 2011 Jan; 52(2):101-11. PubMed ID: 21271550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulatory Effects of Neuroinflammatory Responses Through Brain-Derived Neurotrophic Factor Signaling in Microglial Cells.
    Lai SW; Chen JH; Lin HY; Liu YS; Tsai CF; Chang PC; Lu DY; Lin C
    Mol Neurobiol; 2018 Sep; 55(9):7487-7499. PubMed ID: 29427085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors.
    Kehn-Hall K; Guendel I; Carpio L; Skaltsounis L; Meijer L; Al-Harthi L; Steiner JP; Nath A; Kutsch O; Kashanchi F
    Virology; 2011 Jun; 415(1):56-68. PubMed ID: 21514616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A broad spectrum anti-HIV inhibitor significantly disturbs V1/V2 domain rearrangements of HIV-1 gp120 and inhibits virus entry.
    Berinyuy E; Soliman ME
    J Recept Signal Transduct Res; 2016; 36(2):119-29. PubMed ID: 26446906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Computational design, synthesis and evaluation of new sulphonamide derivatives targeting HIV-1 gp120.
    Vangala R; Sivan SK; Peddi SR; Manga V
    J Comput Aided Mol Des; 2020 Jan; 34(1):39-54. PubMed ID: 31792886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Cinnamon-Derived Procyanidin Compound Displays Anti-HIV-1 Activity by Blocking Heparan Sulfate- and Co-Receptor- Binding Sites on gp120 and Reverses T Cell Exhaustion via Impeding Tim-3 and PD-1 Upregulation.
    Connell BJ; Chang SY; Prakash E; Yousfi R; Mohan V; Posch W; Wilflingseder D; Moog C; Kodama EN; Clayette P; Lortat-Jacob H
    PLoS One; 2016; 11(10):e0165386. PubMed ID: 27788205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sulfated Glycans in HIV Infection and Therapy.
    Pomin VH; Bezerra FF; Soares PAG
    Curr Pharm Des; 2017; 23(23):3405-3414. PubMed ID: 28137224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell-free HIV-1 virucidal action by modified peptide triazole inhibitors of Env gp120.
    Bastian AR; Kantharaju ; McFadden K; Duffy C; Rajagopal S; Contarino MR; Papazoglou E; Chaiken I
    ChemMedChem; 2011 Aug; 6(8):1335-9, 1318. PubMed ID: 21714095
    [No Abstract]   [Full Text] [Related]  

  • 50. Development of a dual reporter screening assay for distinguishing the inhibition of HIV Tat-mediated transcription from off-target effects.
    Shin Y; Choi BS; Kim KC; Kang C; Kim K; Yoon CH
    J Virol Methods; 2017 Nov; 249():1-9. PubMed ID: 28807730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein.
    Marchiò S; Alfano M; Primo L; Gramaglia D; Butini L; Gennero L; De Vivo E; Arap W; Giacca M; Pasqualini R; Bussolino F
    Blood; 2005 Apr; 105(7):2802-11. PubMed ID: 15591114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resistance to the Tat Inhibitor Didehydro-Cortistatin A Is Mediated by Heightened Basal HIV-1 Transcription.
    Mousseau G; Aneja R; Clementz MA; Mediouni S; Lima NS; Haregot A; Kessing CF; Jablonski JA; Thenin-Houssier S; Nagarsheth N; Trautmann L; Valente ST
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 3-Phenylcoumarins as inhibitors of HIV-1 replication.
    Olmedo D; Sancho R; Bedoya LM; López-Pérez JL; Del Olmo E; Muñoz E; Alcamí J; Gupta MP; San Feliciano A
    Molecules; 2012 Aug; 17(8):9245-57. PubMed ID: 22858844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-HIV activity of semisynthetic derivatives of andrographolide and computational study of HIV-1 gp120 protein binding.
    Uttekar MM; Das T; Pawar RS; Bhandari B; Menon V; Nutan ; Gupta SK; Bhat SV
    Eur J Med Chem; 2012 Oct; 56():368-74. PubMed ID: 22858223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of HIV-1 Tat-mediated transcription by a coumarin derivative, BPRHIV001, through the Akt pathway.
    Lin PH; Ke YY; Su CT; Shiao HY; Hsieh HP; Chao YK; Lee CN; Kao CL; Chao YS; Chang SY
    J Virol; 2011 Sep; 85(17):9114-26. PubMed ID: 21697490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The attenuation of HIV-1 Tat-induced neurotoxicity by Salvianic acid A and Danshen granule.
    Bao D; Wang J; Liu J; Qin T; Liu H
    Int J Biol Macromol; 2019 Mar; 124():863-870. PubMed ID: 30503790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases.
    Mandel SA; Amit T; Weinreb O; Reznichenko L; Youdim MB
    CNS Neurosci Ther; 2008; 14(4):352-65. PubMed ID: 19040558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.
    Bugatti A; Urbinati C; Ravelli C; De Clercq E; Liekens S; Rusnati M
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2337-45. PubMed ID: 17452490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Introducing metallocene into a triazole peptide conjugate reduces its off-rate and enhances its affinity and antiviral potency for HIV-1 gp120.
    Gopi H; Cocklin S; Pirrone V; McFadden K; Tuzer F; Zentner I; Ajith S; Baxter S; Jawanda N; Krebs FC; Chaiken IM
    J Mol Recognit; 2009; 22(2):169-74. PubMed ID: 18498083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peptide triazole inactivators of HIV-1: how do they work and what is their potential?
    Chaiken I; Rashad AA
    Future Med Chem; 2015; 7(17):2305-10. PubMed ID: 26599515
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.